These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2446588)

  • 1. Monoamine neurotransmitter interactions and the prediction of antidepressant response.
    Hsiao JK; Agren H; Bartko JJ; Rudorfer MV; Linnoila M; Potter WZ
    Arch Gen Psychiatry; 1987 Dec; 44(12):1078-83. PubMed ID: 2446588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M
    Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes of cerebrospinal fluid monoamine metabolites during long-term antidepressant treatment.
    Bäckman J; Alling C; Alsén M; Regnéll G; Träskman-Bendz L
    Eur Neuropsychopharmacol; 2000 Sep; 10(5):341-9. PubMed ID: 10974605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between clinical symptoms and monoamine metabolite concentrations in biochemically defined subgroups of depressed patients.
    Nordin C
    Acta Psychiatr Scand; 1988 Dec; 78(6):720-9. PubMed ID: 2464903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF amine metabolites and depression.
    Peabody CA; Faull KF; King RJ; Whiteford HA; Barchas JD; Berger PA
    Psychiatry Res; 1987 May; 21(1):1-7. PubMed ID: 2440071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamine metabolites in cerebrospinal fluid of depressed patients during treatment with mianserin or amitriptyline.
    Mendlewicz J; Pinder RM; Stulemeijer SM; Van Dorth R
    J Affect Disord; 1982 Sep; 4(3):219-26. PubMed ID: 6182175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamine neurotransmitter interactions in drug-free and neuroleptic-treated schizophrenics.
    Hsiao JK; Colison J; Bartko JJ; Doran AR; Konicki PE; Potter WZ; Pickar D
    Arch Gen Psychiatry; 1993 Aug; 50(8):606-14. PubMed ID: 7688209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gradients of monoamine metabolites and cortisol in cerebrospinal fluid of psychiatric patients and healthy controls.
    Bertilsson L; Asberg M; Lantto O; Scalia-Tomba GP; Träskman-Bendz L; Tybring G
    Psychiatry Res; 1982 Feb; 6(1):77-83. PubMed ID: 6173891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptom patterns in unipolar and bipolar depression correlating with monoamine metabolites in the cerebrospinal fluid: I. General patterns.
    Agren H
    Psychiatry Res; 1980 Oct; 3(2):211-23. PubMed ID: 6171840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective antidepressants and cerebrospinal fluid. Lack of specificity on norepinephrine and serotonin metabolites.
    Potter WZ; Scheinin M; Golden RN; Rudorfer MV; Cowdry RW; Calil HM; Ross RJ; Linnoila M
    Arch Gen Psychiatry; 1985 Dec; 42(12):1171-7. PubMed ID: 2416297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of CSF monoamine metabolites in poststroke depression: a preliminary report.
    Bryer JB; Starkstein SE; Votypka V; Parikh RM; Price TR; Robinson RG
    J Neuropsychiatry Clin Neurosci; 1992; 4(4):440-2. PubMed ID: 1384852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoamine metabolites as predictors of antidepressant response: a critique.
    Kelwala S; Jones D; Sitaram N
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):229-40. PubMed ID: 6193563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid amine metabolites. Relationships with behavioral measurements in depressed, manic, and healthy control subjects.
    Redmond DE; Katz MM; Maas JW; Swann A; Casper R; Davis JM
    Arch Gen Psychiatry; 1986 Oct; 43(10):938-47. PubMed ID: 2428328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine treatment of depression. Clinical effects, drug concentrations and monoamine metabolites and N-terminally extended substance P in cerebrospinal fluid.
    Mårtensson B; Nyberg S; Toresson G; Brodin E; Bertilsson L
    Acta Psychiatr Scand; 1989 Jun; 79(6):586-96. PubMed ID: 2475012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers.
    De Bellis MD; Geracioti TD; Altemus M; Kling MA
    Biol Psychiatry; 1993 Apr 15-May 1; 33(8-9):636-41. PubMed ID: 7687151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant effect of femoxetine and desipramine and relationship to the concentration of amine metabolites in cerebrospinal fluid. A double-blind evaluation.
    Dahl LE; Lundin L; le Fèvre Honoré P; Dencker SJ
    Acta Psychiatr Scand; 1982 Jul; 66(1):9-17. PubMed ID: 6181653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amino acids in plasma and CSF and monoamine metabolites in CSF: interrelationship in healthy subjects.
    Hagenfeldt L; Bjerkenstedt L; Edman G; Sedvall G; Wiesel FA
    J Neurochem; 1984 Mar; 42(3):833-7. PubMed ID: 6198473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consistent evidence for a biological subtype of depression characterized by low CSF monoamine levels.
    Gibbons RD; Davis JM
    Acta Psychiatr Scand; 1986 Jul; 74(1):8-12. PubMed ID: 2429500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoamine metabolites in CSF and suicidal behavior.
    Träskman L; Asberg M; Bertilsson L; Sjöstrand L
    Arch Gen Psychiatry; 1981 Jun; 38(6):631-6. PubMed ID: 6166274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSF monoamine metabolites and somatostatin in Alzheimer's disease and major depression.
    Molchan SE; Lawlor BA; Hill JL; Martinez RA; Davis CL; Mellow AM; Rubinow DR; Sunderland T
    Biol Psychiatry; 1991 Jun; 29(11):1110-8. PubMed ID: 1714776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.